Management and services for psychosis in People′s Republic of China in 2018
10.3760/cma.j.cn113661-20200622-00290
- VernacularTitle:2018年全国严重精神障碍患者管理治疗现状分析
- Author:
Xun WANG
1
;
Ning MA
;
Xiamin WU
;
Wufang ZHANG
;
Lili GUAN
;
Hong MA
;
Xin YU
;
Lin LU
Author Information
1. 北京大学第六医院公共卫生事业部 北京大学精神卫生研究所 国家卫生健康委员会精神卫生学重点实验室（北京大学） 国家精神心理疾病临床医学研究中心（北京大学第六医院) 100191
- Publication Type:Journal Article
- Keywords:
Mental disorders;
Community mental health services;
Information system
- From:
Chinese Journal of Psychiatry
2020;53(5):438-445
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the management and treatment situation for patients with psychosis in China in 2018, and compare with those in 2014-2017, in order to provide a reference for policy making and services delivering.Methods:Descriptive method was used to analyze the system usage and registration, management and treatment situation of the patients with psychosis, using the data obtained from “National Information System for Psychosis” in China and all provinces (municipalities, autonomous regions), date traced from 1st August 2011 to 31st December 2018.Results:By the end of 2018, the information system was adapted by 2 832 districts/counties, accounting for 99.23% of the total county-level administrative areas (2 832/2 854). 5 994 054 patients were registered, and registered rate was 0.43% (5 994 054/1 379 837 956). In 2018, 5 688 164 patients were provided with follow-up services by primary health care staffs, and the management rate was 94.90% (5 688 164/5 994 054). 4 956 545 patients were followed up regularly, with the regular management rate of 82.69% (4 956 545/5 994 054). Moreover, 4 873 322 patients were treated by taking antipsychotics, with the medication-taking rate of 81.30% (4 873 322/5 994 054), and 2 504 323 patients took medication regularly, with the regular medication-taking rate of 41.78% (2 504 323/5 994 054); 4 426 558 patients were in stable condition and the stability rate was 80.60% (4 426 558/5 492 261), which was positively correlated with the follow-up rate, regular follow-up rate, medication-taking rate and regular medication-taking rate( r=0.509, 0.695, 0.403, 0.539, all P<0.05). Comparing with 2017, there were 187 702 more registered patients in 2018 and all indicators above were higher in 2018. Duration of untreated schizophrenia, bipolar disorder, delusional disorder, schizoaffective disorder, psychotic disorder with epilepsy, mental retardation with psychotic symptoms were 3.54, 4.61, 2.73, 3.18, 5.35, 13.34 years respectively, and the duration of untreated delusional disorder and mental retardation with psychotic symptoms were shorter than those in 2017. Conclusion:Services for patients with psychosis were significantly improved in 2018. The coverage of the information system was expanded. The number of registered patients was sustainably growing. Patient management and pharmacological treatment have both improved.
